Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration. - Wikidata - wikimedia - TriplyDB

Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration.

Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration.

http://www.wikidata.org/entity/Q30539153

about

Ocular Complications of Diabetes and Therapeutic Approaches Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery AAV2 delivery of Flt23k intraceptors inhibits murine choroidal neovascularization Anti-vascular endothelial growth factor therapies in ophthalmology: current use, controversies and the future.Molecular mechanisms of subretinal fibrosis in age-related macular degeneration.Etv2 and fli1b function together as key regulators of vasculogenesis and angiogenesis.Correlation of in vivo and in vitro methods in measuring choroidal vascularization volumes using a subretinal injection induced choroidal neovascularization model.Nanoengineering of therapeutics for retinal vascular disease.Targeted Intraceptor Nanoparticle for Neovascular Macular Degeneration: Preclinical Dose Optimization and Toxicology Assessment.Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1.Microvascular targets for anti-fibrotic therapeutics Immunology of age-related macular degeneration Stem Cell Therapy for Corneal Regeneration Medicine and Contemporary Nanomedicine for Corneal Disorders.Cyclic RGD peptides target human trabecular meshwork cells while ameliorating connective tissue growth factor-induced fibrosis.Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases.Gene delivery nanoparticles to modulate angiogenesis.Long-Term PEDF Release in Rat Iris and Retinal Epithelial Cells after Sleeping Beauty Transposon-Mediated Gene Delivery.Human Vascular Endothelial Growth Factor A Expression Induces the Mouse Model of Neovascular Age-Related Macular Degeneration

P2860

Q26749412-2134DB9F-A68F-4EBF-9DAC-7DBEC930F6F9 Q27007119-CAE6939F-01DC-45AC-8F2B-981130AB188A Q27318539-9ECAD956-2E1A-4F83-955B-1AB9224182B2 Q34554380-1FD3E5FC-AA50-4B2C-A0FF-2A471B37AF10 Q35577823-C9936BB9-F7E3-4F1E-85EC-D2735D16AA86 Q35594958-D3CC0600-6094-47D4-B797-BAEF21C4DFAC Q35645359-74548CCA-CFD0-4337-80D2-606102B6CCA2 Q35645705-4D33E6D8-97B3-45E6-9E0A-D568354B37C1 Q36290649-C46F2AD1-7353-4895-9463-59D42F4F99A7 Q36942442-A60AD7EE-A33B-43BF-861F-FB535780071D Q37358577-087AB57D-0D4B-41A6-B8D2-5790E0D7698F Q37614752-B3F697F5-F5BB-4E97-A51E-30303BE3B0D8 Q38288519-9D17FEC0-177C-40F2-9AEA-461A887E2401 Q38786663-5C18BADD-172F-4503-979E-D092173818E6 Q38829320-84E0B4CB-030F-4BBE-B5E3-7B632EBD2E38 Q39027588-3AC5925A-6B3B-4312-89D9-F3406724FD76 Q46666393-BFB50BE6-341B-4638-B237-183E83FB52C7 Q58779270-7E9E15B1-6A15-4086-B0C8-46A1F0B77F75

P2860

Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration.

http://www.wikidata.org/entity/Q30539153

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Targeted intraceptor nanoparti ...... d murine macular degeneration.

@ast

Targeted intraceptor nanoparti ...... d murine macular degeneration.

@en

type

label

Targeted intraceptor nanoparti ...... d murine macular degeneration.

@ast

Targeted intraceptor nanoparti ...... d murine macular degeneration.

@en

prefLabel

Targeted intraceptor nanoparti ...... d murine macular degeneration.

@ast

Targeted intraceptor nanoparti ...... d murine macular degeneration.

@en

P1433

Q30539153-0536A5BB-EB9B-4BAE-B842-4DB7C728D8BF

P1476

Q30539153-21454C4B-5FDE-437A-9908-AD3A4B874BE9

P2093

Q30539153-0314715C-EF2F-45D4-9D9D-7C6DFF23153B

Q30539153-062C8AE5-3D7E-427F-9C1F-384F23709EE4

Q30539153-0E10E639-16BA-477A-8FD9-F9E733EFC898

Q30539153-1639932E-BB15-4A31-B8FA-61474DF883E7

Q30539153-1F8BAF87-44C9-410D-9D03-6A8B63A75602

Q30539153-22506434-17B7-492C-86FE-71BE604D9BD6

Q30539153-23A62C2C-2FF0-4DBC-9FDD-62E17CABAC8D

Q30539153-3A80F03D-4DE1-4E18-9F2B-1CADC7085990

Q30539153-4073B3A8-E820-4B0D-BB5F-C0CBF06F7607

Q30539153-41B431EF-107C-4D9F-AACC-A465FFCE859F

P2860

Q30539153-00650C39-F27C-4761-AA43-8C0FFFA2372D

Q30539153-0172DBFB-CD19-4F34-96F1-A23BAD0BFE27

Q30539153-06C424A3-F878-4463-80DD-BE15680E518B

Q30539153-131D5622-9B27-438E-B8DE-DB578062B373

Q30539153-15047B96-F108-45C0-A6D8-09340D9E32B0

Q30539153-19502BC3-8D9C-43AD-A9CB-0E5D434412A7

Q30539153-212AD2E3-BECD-4106-AC7B-E9C0C1174097

Q30539153-219A9050-EC3A-4752-AAE0-6B9CCF4D705C

Q30539153-2B90F3A1-4C41-46D5-B345-7F3D6F654C18

Q30539153-2EC4EA52-3661-4259-B217-20F6F03BD19D

P304

Q30539153-8EBB3DF8-28AA-4F88-9772-36A2A4DE96E5

P31

Q30539153-8180E450-8031-4687-AB24-252502C32465

P356

Q30539153-2D7132BE-F012-462F-9434-003C3955CA4A

P407

Q30539153-1B3A0FB7-F123-43D9-9D47-01B2ACD29BA2

P433

Q30539153-B769EAAD-0EBC-4FAB-B8A7-F7A1252E3449

P478

Q30539153-C695530E-0B78-40AA-A23D-74F77306E500

P50

Q30539153-063663EA-5A21-47FA-8EEF-162C44A24317

Q30539153-07966DA9-98A5-44CF-850E-068538352A59

Q30539153-A524E9CF-82FF-4FA9-AB6E-920641B52130

P577

Q30539153-7EE289B3-3B81-4942-AD74-989DBEF028F1

P5875

Q30539153-070A50E4-73C2-405B-AB5E-9E906FACE35C

P698

Q30539153-DCE92934-3A83-42C2-ABEE-E58E2A251054

P921

Q30539153-586A7052-0CFB-4322-8DF4-D2A48140D210

P932

Q30539153-CCDB6311-8512-49A6-9C10-47ADE1BFAF9C

P356

P1433

P1476

Targeted intraceptor nanoparti ...... nd murine macular degeneration

@en

P2093

Balamurali K Ambati

http://www.w3.org/2001/XMLSchema#string

Bonnie Archer

http://www.w3.org/2001/XMLSchema#string

Brian C Stagg

http://www.w3.org/2001/XMLSchema#string

Christina Mamalis

http://www.w3.org/2001/XMLSchema#string

Guangping Gao

http://www.w3.org/2001/XMLSchema#string

Hironori Uehara

http://www.w3.org/2001/XMLSchema#string

Jayakrishna Ambati

http://www.w3.org/2001/XMLSchema#string

Judit Baffi

http://www.w3.org/2001/XMLSchema#string

Kristen Zygmunt

http://www.w3.org/2001/XMLSchema#string

Kyle Jackman

http://www.w3.org/2001/XMLSchema#string

P2860

CCR3 is a target for age-related macular degeneration diagnosis and therapy

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results

Targeted deletion of Vegfa in adult mice induces vision loss

Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function

Molecular mechanisms and clinical applications of angiogenesis

The biology of vascular endothelial growth factor

Ranibizumab for neovascular age-related macular degeneration

2002 global update of available data on visual impairment: a compilation of population-based prevalence studies.

Arg-gly-asp-mannose-6-phosphate inhibits activation and proliferation of hepatic stellate cells in vitro.

P304

3264-3275

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/NN305958Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235879082

http://www.w3.org/2001/XMLSchema#string

P698

23464925

http://www.w3.org/2001/XMLSchema#string

P921

P932

3634882

http://www.w3.org/2001/XMLSchema#string